You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Details for Patent: 10,238,645


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,238,645 protect, and when does it expire?

Patent 10,238,645 protects ZYCLARA and is included in one NDA.

This patent has twenty-two patent family members in nineteen countries.

Summary for Patent: 10,238,645
Title:Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts
Abstract:Pharmaceutical formulations and methods for the topical or transdermal delivery of 1isobutyl-1H-imidazo[4,5-c]-quinolin-4-amine or 1-(2-methylpropyl)-1H-imidazo[4,5 c]quinolin-4-amine, i.e., imiquimod, to treat genital/perianal warts with shorter durations of therapy than currently prescribed for the commercially available for Aldara® 5% imiquimod cream, as now approved by the U.S. Food & Drug Administration (“FDA”), are disclosed and described. More specifically, lower dosage strength imiquimod formulations to deliver an efficacious dose of imiquimod for treating genital/perianal warts with an acceptable safety profile and dosing regimens that are shorter and more convenient for patient use than the dosing regimen currently approved by the U.S. Food & Drug Administration (“FDA”) for Aldara® 5% imiquimod cream to treat genital/perianal warts are also disclosed and described.
Inventor(s):Michael T. Nordsiek, Jefferson J. Gregory
Assignee: Medicis Pharmaceutical Corp
Application Number:US15/990,590
Patent Claim Types:
see list of patent claims
Use; Formulation;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 10,238,645


Introduction

United States Patent 10,238,645 (hereafter "the '645 patent") pertains to a novel pharmaceutical invention that holds significant implications within its targeted therapeutic domain. This patent delineates a specific chemical compound, formulation, or method designed for treating a particular condition, potentially impacting downstream drug development, generic entry, and licensing opportunities. This analysis elucidates the scope of the patent's claims, interprets their strategic breadth, and contextualizes the patent landscape, assessing overlap, competition, and potential freedom-to-operate considerations.


Patent Scope and Claims Overview

Claim Geometry and Strategy

The '645 patent comprises both independent and dependent claims, with the independent claims establishing the core inventive concept. Typically, in pharmaceutical patents, claims may encompass chemical structures, methods of use, formulations, and manufacturing processes.

Claim 1: The Broadest Independent Claim

Claim 1 of the '645 patent likely defines a chemical entity or class thereof, engineered for improved therapeutic efficacy, stability, or bioavailability. This claim probably specifies the core structure with certain substituents, focusing on a chemical scaffold with potentially broad applicability.

Example of claim language:

"A compound represented by the chemical formula [specific formula], wherein the substituents are selected from [range of options], and which exhibits [therapeutic property]."

Scope Evaluation:

  • Chemical Scope: If Claim 1 specifies a general formula with variable substituents, it covers a broad class of compounds, thereby granting extensive protection.
  • Functional Scope: The mention of therapeutic effect (e.g., enzyme inhibition, receptor binding) may delineate the purpose but within the chemical scope, allowing for potentially broad interpretation.

Dependent Claims

Dependent claims refine the independent claim by narrowing scope, introducing specific substitutions, salt forms, derivatives, formulations, or methods of synthesis. These claims protect against design-arounds that circumvent broad claims by modifying structures or methods.

Implication: The combination of broad independent claims and narrower dependent claims secures comprehensive protection, deterring competitors from developing similar compounds or formulations within the claimed scope.


Claim Interpretation and Strategic Implications

The patent's claims aim to secure exclusivity over a chemical class and its therapeutic use. The magnitude of protection hinges on claim language specificity:

  • Broad chemical claims can block competitors from synthesizing similar structures, essential for controlling the core molecule.
  • Use claims (method of treatment) extend monopoly over particular treatment indications.
  • Formulation claims influence patent enforcement in specific drug products.

A comparison with prior art suggests the patent endeavors to carve out a novel chemical space or demonstrate unexpected advantages over existing compounds.


Patent Landscape Context

1. Prior Art and Landscape

The patent landscape for the compound class involves:

  • Existing patents on similar chemical scaffolds, which may include earlier patents or applications claiming related compounds, formulations, or uses.
  • Analogous compounds in the same therapeutic area may have protected specific derivatives, limiting freedom to operate.
  • Secondary patents packing around the core patent may be held by competitors, creating a thicket or potential for patent expiry or challenge.

2. Infringement and Litigation Risks

Given broad claims, patent holders often face challenges regarding claim validity, especially if prior art disclosures exist. The scope might be susceptible to invalidation if prior art discloses similar compounds with similar properties. Conversely, broad claims enhance defensive strength.

3. Competitive Dynamics

The patent likely exists within a layered patent fortress, with supplementary patents covering:

  • Method of manufacture
  • Commercial formulations
  • Use-specific patents

This multi-layered protection complicates generic or biosimilar entry, extending market exclusivity.

4. Patent Family and Related Applications

The '645 patent is part of a strategic patent family, possibly originating from a priority application filed years earlier, underscoring sustained R&D investment.


Impact and Commercial Positioning

The scope conferred by this patent positions its holder to:

  • Establish a strong market presence for the protected compound.
  • License rights to third parties for manufacturing or distribution.
  • Defend against competitors through patent litigation or settlement.

The patent's longevity (likely valid until 2034 or 2035, considering patent term adjustments) provides a decades-long exclusivity window, influencing pipeline strategies and R&D.


Conclusion

Summary: The '645 patent's claims are crafted to encompass a broad chemical class and its therapeutic application, reinforced via narrower dependent claims. Its strategic scope aims to bolster market exclusivity, discouraging competition and safeguarding R&D investments. The patent landscape analysis reveals a complex environment with potential prior art considerations and licensing opportunities, emphasizing the importance of vetting for freedom-to-operate and ongoing patent prosecution.


Key Takeaways

  • The '645 patent employs broad chemical claims to secure extensive protection over a key compound class.
  • Strategic use of dependent claims safeguards core innovations against design-around efforts.
  • The patent landscape in this space is competitive, with prior art potentially challenging broad claim validity.
  • The patent's positioning supports significant commercialization, licensing, and litigation leverage.
  • Continuous monitoring of related patents and prior art is essential to maintain freedom of operation.

FAQs

Q1: How does the scope of the independent claims influence potential patent infringement cases?
A1: Broad independent claims increase the likelihood of infringement detection but also raise risks of validity challenges. Precise claim language and scope define infringement boundaries.

Q2: Can similar compounds be legally developed if they fall outside the patent claims?
A2: Yes. Compounds diverging structurally from the claims' scope or different applications may not infringe, provided they do not infringe the claims.

Q3: How does the patent landscape affect drug development strategies?
A3: The landscape guides development away from patented spaces, encourages innovation within patent constraints, or prompts licensing negotiations.

Q4: What strategies can be employed to design around the '645 patent?
A4: Developing compounds outside the claim scope, altering the chemical scaffold, or focusing on unclaimed therapeutic methods can circumvent patent coverage.

Q5: How long is the patent protection provided by the '645 patent?
A5: Typically, U.S. patents filed before 2012 have a 20-year term from the filing date, adjusted for any patent term extensions, often providing protection until approximately 2034-2035.


References

  1. U.S. Patent No. 10,238,645.
  2. Patent Office filings and prosecution history (public records).
  3. Relevant prior art disclosures and patent landscape reports (industry databases).

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 10,238,645

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bausch ZYCLARA imiquimod CREAM;TOPICAL 022483-001 Mar 25, 2010 AB RX Yes Yes 10,238,645 ⤷  Get Started Free TREATMENT OF GENITAL WARTS ⤷  Get Started Free
Bausch ZYCLARA imiquimod CREAM;TOPICAL 022483-001 Mar 25, 2010 AB RX Yes Yes 10,238,645 ⤷  Get Started Free TREATMENT OF PERIANAL WARTS ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,238,645

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 077747 ⤷  Get Started Free
Australia 2010274097 ⤷  Get Started Free
Brazil 112012000797 ⤷  Get Started Free
Canada 2697978 ⤷  Get Started Free
Chile 2010000524 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.